Does PANOBINOSTAT Cause Second primary malignancy? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Second primary malignancy have been filed in association with PANOBINOSTAT. This represents 0.3% of all adverse event reports for PANOBINOSTAT.
6
Reports of Second primary malignancy with PANOBINOSTAT
0.3%
of all PANOBINOSTAT reports
3
Deaths
2
Hospitalizations
How Dangerous Is Second primary malignancy From PANOBINOSTAT?
Of the 6 reports, 3 (50.0%) resulted in death, 2 (33.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANOBINOSTAT. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does PANOBINOSTAT Cause?
Diarrhoea (368)
Plasma cell myeloma (279)
Platelet count decreased (192)
Death (190)
Malignant neoplasm progression (166)
Fatigue (162)
Nausea (154)
Thrombocytopenia (141)
Off label use (112)
Vomiting (109)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which PANOBINOSTAT Alternatives Have Lower Second primary malignancy Risk?
PANOBINOSTAT vs PANTOPRAZOLE
PANOBINOSTAT vs PANTOPRAZOLE ANHYDROUS
PANOBINOSTAT vs PANTOTHENIC ACID
PANOBINOSTAT vs PAPAVERINE
PANOBINOSTAT vs PARACETAMOL